194 related articles for article (PubMed ID: 4322937)
21. [The cellular microenvironment of malignant tumors and its significance in their prognosis].
Leenman EE; Mukhina MS
Vopr Onkol; 2013; 59(4):444-52. PubMed ID: 24032217
[No Abstract] [Full Text] [Related]
22. Human tumor-associated antigens identified by monoclonal antibodies.
Hellström KE; Hellström I; Brown JP
Springer Semin Immunopathol; 1982; 5(2):127-46. PubMed ID: 6183764
[No Abstract] [Full Text] [Related]
23. Cell-mediated and humoral immune reactions to human tumours.
Baldwin RW; Embleton MJ; Jones JS; Langman MJ
Int J Cancer; 1973 Jul; 12(1):73-83. PubMed ID: 4790710
[No Abstract] [Full Text] [Related]
24. [Immunological exploration of cancer patients. II. Tumoral immunity].
Cappelaere P; Demaille A; Adenis L
Lille Med; 1973 Feb; 18(2):179-201. PubMed ID: 4581842
[No Abstract] [Full Text] [Related]
25. [Symtomatology of immunobiological reactions in the early stage of cancer].
Müller J; Sturík J; Kepertová A
Wien Z Inn Med; 1966 Feb; 47(2):61-5. PubMed ID: 6005155
[No Abstract] [Full Text] [Related]
26. Specific and non-specific immunologic reactivity of regional lymph-node lymphocytes in human malignancy.
Ambus U; Mavlight GM; Gutterman JU; McBride CM; Hersh EM
Int J Cancer; 1974 Sep; 14(3):291-300. PubMed ID: 4142467
[No Abstract] [Full Text] [Related]
27. Human tumor immunology.
Oettgen HF; Old LJ; Boyse EA
Med Clin North Am; 1971 May; 55(3):761-85. PubMed ID: 4995918
[No Abstract] [Full Text] [Related]
28. Expression of MHC-class-I antigens in human carcinomas and sarcomas analyzed by isoelectric focusing.
Wang P; Vánky F; Li SL; Végh Z; Persson U; Klein E
Int J Cancer Suppl; 1991; 6():106-16. PubMed ID: 2066176
[TBL] [Abstract][Full Text] [Related]
29. Lymphocyte cytotoxicity against allogeneic cultured cells in gynecologic malignancy.
Arata T; Momozaki F; Kazuta M; Yamamoto H; Sekiba K
Acta Med Okayama; 1979 Jun; 33(3):197-204. PubMed ID: 158947
[TBL] [Abstract][Full Text] [Related]
30. Cellular immunity against tumor-associated antigens in humans: lymphocyte stimulation and skin reaction.
Vánky R; Klein E; Stjernswärd J; Nilsonne U
Int J Cancer; 1974 Aug; 14(2):277-88. PubMed ID: 4376515
[No Abstract] [Full Text] [Related]
31. Carcinoma-associated mucin serum markers CA M26 and CA M29: efficacy in detecting and monitoring patients with cancer of the breast, colon, ovary, endometrium and cervix.
Yedema KA; Kenemans P; Wobbes T; van Kamp GJ; de Bruijn HW; Thomas CM; Massuger LF; Schijf CP; Bon GG; Vermorken JB
Int J Cancer; 1991 Jan; 47(2):170-9. PubMed ID: 1988362
[TBL] [Abstract][Full Text] [Related]
32. Oncofetal antigen-I: distribution in human tumors.
Rees WV; Irie RF; Morton DL
J Natl Cancer Inst; 1981 Sep; 67(3):557-62. PubMed ID: 6268878
[TBL] [Abstract][Full Text] [Related]
33. Evidence for fetal antigen in human sarcoma.
Mukherji B; Hirshaut Y
Science; 1973 Aug; 181(4098):440-2. PubMed ID: 4577921
[TBL] [Abstract][Full Text] [Related]
34. Specific antibody activation of lymphocytes for cell-mediated cytotoxicity against cultured target cells.
Takasugi M; Kinoshita K
J Natl Cancer Inst; 1974 Dec; 53(6):1539-44. PubMed ID: 4474407
[No Abstract] [Full Text] [Related]
35. Identification of a new oncofoetal antigen associated with several types of human carcinomas.
Fritsché R; Mach J
Nature; 1975 Dec; 258(5537):734-7. PubMed ID: 1207757
[No Abstract] [Full Text] [Related]
36. [Immunosuppression: a paraneoplastic syndrome].
Nagel GA
Schweiz Med Wochenschr; 1971 Apr; 101(13):470-4. PubMed ID: 5283773
[No Abstract] [Full Text] [Related]
37. Cell-mediated cytotoxicity against human bladder cancer.
Bloom ET; Ossorio RC; Brosman SA
Int J Cancer; 1974 Sep; 14(3):326-34. PubMed ID: 4477556
[No Abstract] [Full Text] [Related]
38. Inhibition of lymphocyte cytotoxicity for human colon carcinoma by treatment with solubilized tumour membrane fractions.
Baldwin RW; Embleton MJ; Price MR
Int J Cancer; 1973 Jul; 12(1):84-92. PubMed ID: 4790711
[No Abstract] [Full Text] [Related]
39. Demonstration of cell-mediated and blocking immune responses to tumor antigens in cancer patients with the colony-inhibition-in-gel test.
Cummings FJ; Heppner GH; Stolbach L; Calabresi P
Isr J Med Sci; 1973 Mar; 9(3):308-16. PubMed ID: 4710038
[No Abstract] [Full Text] [Related]
40. Specificity of delayed cutaneous hypersensitivity reactions to extracts of human tumor cells.
Weese JL; Herberman RB; Hollinshead AC; Cannon GB; Keels M; Kibrite A; Morales A; Char DH; Oldham RK
J Natl Cancer Inst; 1978 Feb; 60(2):255-63. PubMed ID: 74413
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
